Manuel Praga

13PUBLICATIONS
23CO-AUTHORS
HaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteinsMolecular medicineCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 24, 2026
Hematuria as a biomarker guiding treatment decisions in IgA nephropathy? Yes.

Eduardo Gutiérrez, Angel Sevillano, Manuel Praga

|Sep 25, 2025
Antiproteinuric effect of SGLT2 inhibitors in non-diabetic glomerulopathies is dependent on body mass index.

Maria J Vargas-Brochero, Ilario Russo, Tommaso Mazzierli

|Sep 03, 2025
Identification of early predictors of clinical remission in primary membranous nephropathy: a post hoc analysis of the STARMEN trial.

Jorge E Rojas-Rivera, Fernando Caravaca-Fontán, Anne-Els van de Logt

|Feb 20, 2025
A predicting tool for kidney function recovery after drug-induced acute interstitial nephritis.

Fernando Caravaca-Fontán, Marina Alonso-Riaño, Amir Shabaka

|Dec 17, 2024
Tailored management strategies for IgA nephropathy based on clinical presentations.

Manuel Praga, Fernando Caravaca-Fontán, Iara Da Silva

|Jun 25, 2024
Apolipoprotein E in dense deposits: a parting of the ways in C3 glomerulopathy.

Joana Tavares, Fernando Caravaca-Fontán, Manuel Praga

Pageof 3

Frequent Collaborators

11 joint publications

Fernando Caravaca-Fontán

4 joint publications

Amir Shabaka

3 joint publications

Luis F Quintana

2 joint publications

Hernando Trujillo